Drew Weissman
Sign in to saveAmerican physician-scientist (born 1959)
Person
- Born
- 1959-09-07
via Open Library + Wikidata
Recent publications · Crossref
5 total works indexed
- The blockade of immune checkpoints in cancer immunotherapy
· 2012 · cited 11,783x
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
· 2012 · cited 10,715x
- A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
· 2012 · cited 9,212x
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
· 2015 · cited 8,103x
- Stem cells, cancer, and cancer stem cells
· 2001 · cited 7,565x
via Crossref · CC0
Key facts
- Born
- ( 1959-09-07 ) September 7, 1959 (age 66) , Lexington, Massachusetts , U.S.
- Education
- Brandeis University ( BA , MA ) Boston University ( MD , PhD )
- Known for
- Modified mRNA technologies used in COVID-19 vaccines
- Awards
- Rosenstiel Award (2020) Lasker–DeBakey Clinical Medical Research Award (2021) VinFuture Prize (2022) Breakthrough Prize in Life Sciences (2022) Harvey Prize (2023) Nobel Prize in Physiology or Medicine (2023)
- Fields
- Immunology
- Institutions
- University of Pennsylvania
- Thesis
- Regulation of b lymphocytes with reagents that cross-link surface immunoglobulin (1987)
- Doctoral advisor
- Ann Marshak-Rothstein
via Wikipedia infobox
Key dates
- Born
- 7 September 1959
via Wikidata · CC0
Wikidata facts
- Instance of
- human
- Gender
- male
- Citizenship
- United States
- Place of birth
- Lexington
- Occupation
- immunologist
- Educated at
- Boston University
- Employer
- University of Pennsylvania
- Languages spoken
- English language
- Religion
- Judaism
- Award
- John Scott Award
Article
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With biochemist Katalin Karikó, Weissman received the Nobel Prize in Physiology or Medicine in 2023 "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19". Weissman has been a recipient and co-recipient of numerous awards, also including the prestigious Lasker–DeBakey Clinical Medical Research Award. In 2022, he was elected to the National Academy of Medicine and the American Academy of Arts and Sciences.
Gallery (2)
Connections
Categories
1959 births20th-century American biologists20th-century American chemists20th-century American medical doctors21st-century American biologists21st-century American chemists21st-century American Jews21st-century American medical doctorsAmerican biochemistsAmerican Nobel laureatesAmerican people of German-Jewish descentAmerican people of Italian descent